| Product Code: ETC12465583 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Immunotherapy Drugs Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Immunotherapy Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Immunotherapy Drugs Market - Industry Life Cycle |
3.4 Israel Immunotherapy Drugs Market - Porter's Five Forces |
3.5 Israel Immunotherapy Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Israel Immunotherapy Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Israel Immunotherapy Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Israel Immunotherapy Drugs Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.9 Israel Immunotherapy Drugs Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 Israel Immunotherapy Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases in Israel |
4.2.2 Growing investments in research and development of immunotherapy drugs |
4.2.3 Favorable government initiatives to promote adoption of immunotherapy treatments |
4.3 Market Restraints |
4.3.1 High cost associated with immunotherapy drugs |
4.3.2 Stringent regulatory requirements for drug approval in Israel |
5 Israel Immunotherapy Drugs Market Trends |
6 Israel Immunotherapy Drugs Market, By Types |
6.1 Israel Immunotherapy Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Immunotherapy Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Israel Immunotherapy Drugs Market Revenues & Volume, By Checkpoint Inhibitors, 2021 - 2031F |
6.1.4 Israel Immunotherapy Drugs Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.5 Israel Immunotherapy Drugs Market Revenues & Volume, By Cancer Vaccines, 2021 - 2031F |
6.1.6 Israel Immunotherapy Drugs Market Revenues & Volume, By Cytokines, 2021 - 2031F |
6.1.7 Israel Immunotherapy Drugs Market Revenues & Volume, By Adoptive T-Cell Therapy, 2021 - 2031F |
6.2 Israel Immunotherapy Drugs Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Immunotherapy Drugs Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Israel Immunotherapy Drugs Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Israel Immunotherapy Drugs Market Revenues & Volume, By Melanoma, 2021 - 2031F |
6.2.5 Israel Immunotherapy Drugs Market Revenues & Volume, By Leukemia, 2021 - 2031F |
6.2.6 Israel Immunotherapy Drugs Market Revenues & Volume, By Multiple Myeloma, 2021 - 2031F |
6.3 Israel Immunotherapy Drugs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Immunotherapy Drugs Market Revenues & Volume, By Oncology Centers, 2021 - 2031F |
6.3.3 Israel Immunotherapy Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Israel Immunotherapy Drugs Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Israel Immunotherapy Drugs Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.3.6 Israel Immunotherapy Drugs Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 Israel Immunotherapy Drugs Market, By Mechanism of Action |
6.4.1 Overview and Analysis |
6.4.2 Israel Immunotherapy Drugs Market Revenues & Volume, By PD-1/PD-L1 Blocking, 2021 - 2031F |
6.4.3 Israel Immunotherapy Drugs Market Revenues & Volume, By Immune System Activation, 2021 - 2031F |
6.4.4 Israel Immunotherapy Drugs Market Revenues & Volume, By Tumor Cell Recognition, 2021 - 2031F |
6.4.5 Israel Immunotherapy Drugs Market Revenues & Volume, By Signal Pathway Modulation, 2021 - 2031F |
6.4.6 Israel Immunotherapy Drugs Market Revenues & Volume, By CAR-T Cell Therapy, 2021 - 2031F |
6.5 Israel Immunotherapy Drugs Market, By Sales Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Immunotherapy Drugs Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.5.3 Israel Immunotherapy Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.4 Israel Immunotherapy Drugs Market Revenues & Volume, By Wholesale Suppliers, 2021 - 2031F |
6.5.5 Israel Immunotherapy Drugs Market Revenues & Volume, By Government Procurement, 2021 - 2031F |
6.5.6 Israel Immunotherapy Drugs Market Revenues & Volume, By Hospital Contracts, 2021 - 2031F |
7 Israel Immunotherapy Drugs Market Import-Export Trade Statistics |
7.1 Israel Immunotherapy Drugs Market Export to Major Countries |
7.2 Israel Immunotherapy Drugs Market Imports from Major Countries |
8 Israel Immunotherapy Drugs Market Key Performance Indicators |
8.1 Number of clinical trials conducted for immunotherapy drugs in Israel |
8.2 Adoption rate of immunotherapy drugs by healthcare providers in Israel |
8.3 Patient survival rates and improvement in quality of life after using immunotherapy treatments |
9 Israel Immunotherapy Drugs Market - Opportunity Assessment |
9.1 Israel Immunotherapy Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Israel Immunotherapy Drugs Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Israel Immunotherapy Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Israel Immunotherapy Drugs Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.5 Israel Immunotherapy Drugs Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
10 Israel Immunotherapy Drugs Market - Competitive Landscape |
10.1 Israel Immunotherapy Drugs Market Revenue Share, By Companies, 2024 |
10.2 Israel Immunotherapy Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here